Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system

被引：0
|
作者：
Greiner, R. -A. [1 ]
Braathen, L. R. [1 ]
机构：
[1] Inselspital Bern, Univ Clin Dermatol, Bern, Switzerland
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2008年 / 159卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1427 / 1427
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system
    Greiner, Roger-Axel
    Braathen, Lasse R.
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (05) : 494 - 499
  • [2] Cost effectiveness of biologics for moderate to severe psoriasis from the perspective of the Swiss healthcare system
    Greiner, R.
    Braathen, L. R.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 54 - 54
  • [3] Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective
    Jinsui Zhang
    Zemin Xia
    Wanjie Guo
    Xiaoxiao Ren
    Fang Liu
    Gargi Ratnaparkhi
    Amit Pagada
    Subhashini Subramanian
    Min Hu
    Wen Chen
    [J]. Dermatology and Therapy, 2023, 13 : 2681 - 2696
  • [4] Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective
    Zhang, Jinsui
    Xia, Zemin
    Guo, Wanjie
    Ren, Xiaoxiao
    Liu, Fang
    Ratnaparkhi, Gargi
    Pagada, Amit
    Subramanian, Subhashini
    Hu, Min
    Chen, Wen
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2681 - 2696
  • [5] COST-EFFECTIVENESS ANALYSIS OF BIOSIMILARS AND NOVEL BIOLOGICS FOR PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS
    Leong, N. W.
    Yang, Y.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S108 - S109
  • [6] The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis
    Rouse, Nicole C.
    Farhangian, Michael E.
    Wehausen, Brooke
    Feldman, Steven R.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (06) : 877 - 884
  • [7] Cost-effectiveness of treatment for moderate-to-severe psoriasis
    Hankin, CS
    Feldman, SR
    Pearce, D
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 654 - 654
  • [8] Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective
    Igarashi, Atsuyuki
    Igarashi, Ataru
    Graham, Christopher N.
    Gilloteau, Isabelle
    Tani, Yumiko
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (01) : 7 - 15
  • [9] COST-EFFECTIVENESS OF APREMILAST IN MODERATE-TO-SEVERE PSORIASIS IN CANADA
    Cawston, H.
    Damera, V
    Ektare, V
    Shear, N. H.
    Tencer, T.
    Liu, F. F.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A587 - A587
  • [10] COST-EFFECTIVENESS OF USTEKINUMAB IN THE MANAGEMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN MEXICO
    Valencia-Mendoza, A.
    Hernandez-Garduno, A.
    Puig, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A513 - A514
12345